{"transactions":[{"id":683651,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:00:09.000Z","date":"2026-08-17","kind":"gift","planned":false,"acquired":true,"shares":208073,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":300136,"source":{"system":"sec-edgar","filing":"0001193125-26-355661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526355661/ownership.xml","form_type":"4"}},{"id":683650,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:00:09.000Z","date":"2026-08-17","kind":"gift","planned":false,"acquired":false,"shares":208073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-355661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526355661/ownership.xml","form_type":"4"}},{"id":683649,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:00:09.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":208073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones."}],"balance_after":208073,"source":{"system":"sec-edgar","filing":"0001193125-26-355661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526355661/ownership.xml","form_type":"4"}},{"id":795785,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-01T21:31:42.000Z","date":"2026-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":13285,"price":1.1,"value":14613.5,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.09 to $1.13, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":92063,"source":{"system":"sec-edgar","filing":"0001193125-26-201764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526201764/ownership.xml","form_type":"4"}},{"id":917816,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:29:23.000Z","date":"2026-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":13100,"price":1.65,"value":21615.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All share numbers reflect a 1-for-4 reverse stock split effective January 28, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.63 to $1.66, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"All share numbers reflect a 1-for-4 reverse stock split effective January 28, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":105348,"source":{"system":"sec-edgar","filing":"0001193125-26-039686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526039686/ownership.xml","form_type":"4"}},{"id":941096,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:17:29.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":78145,"price":0.9,"value":70330.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":473790,"source":{"system":"sec-edgar","filing":"0001193125-26-010642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526010642/ownership.xml","form_type":"4"}},{"id":1010690,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-31T16:55:28.000Z","date":"2025-10-29","kind":"grant","planned":false,"acquired":true,"shares":390614,"price":1.28,"value":499985.92,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":395645,"source":{"system":"sec-edgar","filing":"0001193125-25-260417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312525260417/ownership.xml","form_type":"4"}},{"id":1269726,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-13T23:05:34.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":15048,"price":3.87,"value":58235.76,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee."}],"balance_after":15076,"source":{"system":"sec-edgar","filing":"0000950170-25-020104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025020104/ownership.xml","form_type":"4"}},{"id":1987360,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22276,"kind":"person","name":"Zygmont Chester Stanley III","position":1,"cik":"0001900657","reported_name":"Zygmont Chester Stanley III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-28T21:09:40.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on 2/25/2022 and  vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":49,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":611},"source":{"system":"sec-edgar","filing":"0001209191-23-013633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123013633/doc4.xml","form_type":"4"}}]}